Literature DB >> 23557397

Do women and providers value the same features of contraceptive products? Results of a best-worst stated preference experiment.

Edith Weisberg1, Deborah Bateson, Stephanie Knox, Marion Haas, Rosalie Viney, Deborah Street, Denzil Fiebig.   

Abstract

OBJECTIVES: To determine how women and physicians rate individual characteristics of contraceptives.
METHODS: Discrete choice experiments are used in health economics to elicit preferences for healthcare products. A choice experiment uses hypothetical scenarios to determine which individual factors influence choice. Women and general practitioners (GPs) were shown individual characteristics of contraceptives, not always matching existing methods, and chose the best and worst features.
RESULTS: Two hundred women, mean age 36, 71% using contraception, were presented with descriptions of 16 possible methods and asked to indicate their preference for individual characteristics. One hundred and sixty-two GPs, mostly women, also completed 16 descriptions. Longer duration of action was most favoured by both, followed by lighter periods with less pain or amenorrhoea. The least attractive features for women were heavier and more painful periods, high cost, irregular periods, low efficacy (10% failure) and weight gain of 3 kg. GPs ranked a 10% pregnancy rate as least attractive followed by heavy painful periods and a 5% failure rate.
CONCLUSION: Women and GPs differed in their ranking of contraceptive characteristics. Long duration of use, high efficacy, minimal or no bleeding without pain, were preferred by both. Very undesirable were heavy periods especially with pain, and low efficacy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23557397     DOI: 10.3109/13625187.2013.777830

Source DB:  PubMed          Journal:  Eur J Contracept Reprod Health Care        ISSN: 1362-5187            Impact factor:   1.848


  6 in total

1.  Development and field testing of a decision support tool to facilitate shared decision making in contraceptive counseling.

Authors:  Christine Dehlendorf; Judith Fitzpatrick; Jody Steinauer; Lawrence Swiader; Kevin Grumbach; Cara Hall; Miriam Kuppermann
Journal:  Patient Educ Couns       Date:  2017-02-10

Review 2.  Provider and lay perspectives on intra-uterine contraception: a global review.

Authors:  Marina A S Daniele; John Cleland; Lenka Benova; Moazzam Ali
Journal:  Reprod Health       Date:  2017-09-26       Impact factor: 3.223

3.  Developing an Assessment of Contraceptive Preferences in Botswana: Piloting a Novel Approach Using Best-Worst Scaling of Attributes.

Authors:  Alida M Gertz; Ahmad Syahir Mohd Soffi; Atlang Mompe; Ontiretse Sickboy; Averi N Gaines; Rebecca Ryan; Aamirah Mussa; Caitlin Bawn; Robert Gallop; Chelsea Morroni; Paul Crits-Christoph
Journal:  Front Glob Womens Health       Date:  2022-05-18

4.  A Qualitative Exploration of Women's Interest in Long-Acting Injectable Antiretroviral Therapy Across Six Cities in the Women's Interagency HIV Study: Intersections with Current and Past Injectable Medication and Substance Use.

Authors:  Morgan M Philbin; Carrigan Parish; Sadie Bergen; Deanna Kerrigan; Elizabeth N Kinnard; Sarah E Reed; Mardge H Cohen; Oluwakemi Sosanya; Anandi N Sheth; Adaora A Adimora; Jennifer Cocohoba; Lakshmi Goparaju; Elizabeth T Golub; Margaret Fischl; Maria L Alcaide; Lisa R Metsch
Journal:  AIDS Patient Care STDS       Date:  2021-01       Impact factor: 5.078

5.  Health workers' values and preferences regarding contraceptive methods globally: A systematic review.

Authors:  Komal S Soin; Ping Teresa Yeh; Mary E Gaffield; Christina Ge; Caitlin E Kennedy
Journal:  Contraception       Date:  2022-05-05       Impact factor: 3.051

6.  Optimizing the design of a contraceptive microarray patch: a discrete choice experiment on women's preferences in India and Nigeria.

Authors:  Rebecca L Callahan; Aurélie Brunie; Victoria Lebrun; Mario Chen; Christine L Godwin; Kanchan Lakhwani; Funmilola M OlaOlorun
Journal:  Reprod Health       Date:  2021-03-22       Impact factor: 3.223

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.